Fred Cohen Appointed to Biocryst Pharmaceuticals’s Board of Directors

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Fred E. Cohen, M.D., D.Phil., was elected to the Company's Board of Directors.

“The Board of Directors and Leadership Team of BioCryst are very pleased to have Fred join the Company’s Board,” said George B. Abercrombie, Chairman of the Board of BioCryst.

Help employers find you! Check out all the jobs and post your resume.

Back to news